MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic Juveni
MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic Juveni
批准号:
8900744
负责人:
ALEXEI A GROM
金额:
$34.43万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-08 至 2017-07-31
关键词:
Abnormal CellAddressApoptosisBIRC5 geneBiological AssayBiological MarkersCell CycleCell PolarityCell physiologyCellsChronic Childhood ArthritisComplicationCytoplasmic GranulesDNADataDefectDepressed moodDevelopmentDiseaseExocytosisFrequenciesFunctional disorderGene ExpressionGene TargetingGenesGenetic MarkersGenetic PolymorphismGenotypeGoalsHaplotypesHereditary DiseaseImmuneImmune responseIncidenceInflammationInflammatoryInflammatory ResponseInheritedIntracellular TransportLeadLinkLymphocyte FunctionMacrophage ActivationMolecular ProfilingMutationNatural Killer CellsPatientsPeripheral Blood Mononuclear CellPlayPromoter RegionsProteinsPublishingReactionRegulationReportingResearchRiskRoleSamplingSecondary toSingle Nucleotide PolymorphismSyndromeT-LymphocyteTissue-Specific Gene ExpressionUNC13B geneVirusclinical practicecohortcytotoxicdifferential expressionfamilial hemophagocytic lymphohistiocytosisinterestkillingsmacrophagemast cellneoplastic cellneutrophilperforinuncontrolled T lymphocyte proliferation
中文摘要
描述(由申请人提供): 巨噬细胞活化综合征(MAS)是全身性幼年特发性关节炎的一种严重的、潜在致命的并发症。在临床实践中,迫切需要可靠的生物标志物来识别有这种并发症风险的患者。MAS是由过度的炎症反应引起的,主要涉及两种类型的免疫细胞-巨噬细胞和T淋巴细胞。在临床上类似的遗传条件下,过度免疫应答的发展与溶细胞细胞功能缺陷有关。这些细胞通常杀死异常细胞,如肿瘤细胞或被病毒感染的细胞。有一些证据表明,溶细胞细胞也可能参与消除过度活化的免疫细胞。因此,如果它们不能正常发挥作用,免疫反应可能无法及时终止。这将导致在MAS中观察到的不受控制的炎症。以前,我们已经确定了MUNC 13 -4基因内的几个遗传标记作为一个单一的单倍型遗传。由于MUNC 13 -4蛋白参与细胞溶解功能,因此该观察结果是重要的。一个重要的未回答的问题是MUNC 13-4中单倍型的存在是否与MUNC 13 -4蛋白的异常功能相关,从而直接导致在MAS患者中观察到的细胞溶解功能障碍的发展。另一种可能性是所述单倍型可以延伸到MUNC 13 -4基因的上游或下游,并涉及邻近免疫相关基因中的额外多态性。拟议的研究将探讨这两种可能性。
英文摘要
DESCRIPTION (provided by applicant): Macrophage activation syndrome (MAS) is a serious, potentially fatal complication of Systemic Juvenile Idiopathic Arthritis. In clinical practice, there is a strong need for reliable biomarkers that would identify patients at risk for this complication. MAS is caused by the exaggerated inflammatory response involving mainly two types of immune cells - macrophages and T lymphocytes. In clinically similar genetic conditions the development of the exaggerated immune response has been linked to defective function of cytolytic cells. These cells typically kill abnormal cells such as tumor cells or cells infected with viruses. There is some evidence that cytolytic cells may also be involved in the elimination of overly activated immune cells. Therefore, if they do not function properly, the immune response may not be terminated in a timely manner. This would lead to uncontrolled inflammation seen in MAS. Previously, we have identified several genetic markers within the MUNC13-4 gene inherited as a single haplotype. Since MUNC13-4 protein is involved with the cytolytic function this observations is important. An important unanswered question is whether the presence of the haplotype in the MUNC 13-4 is associated with abnormal function of the MUNC13-4 protein and, thus, directly contributes to the development of cytolytic dysfunction seen in patients MAS. Another possibility is that the described haplotype may extend either upstream or downstream of the MUNC13-4 gene and involve additional polymorphisms in the neighboring immunologically relevant genes. These two possibilities will be explored in the proposed study.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
激活的 NLRC4 炎性体突变会导致自身炎症,并伴有复发性巨噬细胞激活综合征。
DOI:
10.1038/ng.3089
发表时间:
2014-10
期刊:
NATURE GENETICS
影响因子:
30.8
作者:
[Canna, Scott W., de Jesus, Adriana A., Gounil, Sushanth, Brooks, Stephen R., Marrero, Bernadette, Liu, Yin, DiMattia, Michael A., Zaal, Kristien J. M., Sanchez, Gina A. Montealegre, Kim, Hanna, Chapelle, Dawn, Plass, Nicole, Huang, Yan, Villarinol, Alejandro V., Biancotto, Angelique, Fleisher, Thomas A., Duncan, Joseph A., O'Shea, John J., Benseler, Susanne, Grom, Alexei, Deng, Zuoming, Laxer, Ronald M., Goldbach-Mansky, Raphaela]
通讯作者:
Goldbach-Mansky, Raphaela
DOI:
10.1097/bor.0000000000000098
发表时间:
2014-09
期刊:
Current opinion in rheumatology
影响因子:
5.1
作者:
[Nirmala N, Grom A, Gram H]
通讯作者:
Gram H
CINCINNATI TRAINING PROGRAM IN PEDIATRIC RHEUMATOLOGYRESEARCH
-
批准号:10858484
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2023
-
负责人:ALEXEI A GROM
-
依托单位:
CINCINNATI TRAINING PROGRAM IN PEDIATRIC RHEUMATOLOGY RESEARCH
-
批准号:9248872
-
项目类别:
-
资助金额:$14.52万
-
财政年份:2016
-
负责人:ALEXEI A GROM
-
依托单位:
CINCINNATI TRAINING PROGRAM IN PEDIATRIC RHEUMATOLOGYRESEARCH
-
批准号:10682443
-
项目类别:
-
资助金额:$14.17万
-
财政年份:2016
-
负责人:ALEXEI A GROM
-
依托单位:
CINCINNATI TRAINING PROGRAM IN PEDIATRIC RHEUMATOLOGYRESEARCH
-
批准号:10266008
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2016
-
负责人:ALEXEI A GROM
-
依托单位:
CINCINNATI TRAINING PROGRAM IN PEDIATRIC RHEUMATOLOGY RESEARCH
-
批准号:9072823
-
项目类别:
-
资助金额:$7.03万
-
财政年份:2016
-
负责人:ALEXEI A GROM
-
依托单位:
Macrophage Activation Syndrome Biomarkers in Systemic Juvenile Idiopathic Art
-
批准号:8382402
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2012
-
负责人:ALEXEI A GROM
-
依托单位:
MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic Juveni
-
批准号:8514526
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2011
-
负责人:ALEXEI A GROM
-
依托单位:
MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic Juveni
-
批准号:8717401
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2011
-
负责人:ALEXEI A GROM
-
依托单位:
MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic Juveni
-
批准号:8039690
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2011
-
负责人:ALEXEI A GROM
-
依托单位:
MUNC13-4 gene Polymorphisms in Macrophage Activation syndrome and Systemic Juveni
-
批准号:8316099
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2011
-
负责人:ALEXEI A GROM
-
依托单位:
Macrophage Activation Syndrome Biomarkers in Systemic Juvenile Idiopathic Art
-
批准号:7475985
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2008
-
负责人:ALEXEI A GROM
-
依托单位:
Gene Expression Profiles in Systemic Onset Juvenile Rheumatoid Arthritis...
-
批准号:7497454
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2007
-
负责人:ALEXEI A GROM
-
依托单位:
Pathobiology of the Monomyelocytoid Cell Gene Expression Signature in SystemicJIA
-
批准号:8532637
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2003
-
负责人:ALEXEI A GROM
-
依托单位:
Pathogenic Mechanisms of the Vasculopathy of JDM
-
批准号:6805675
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2003
-
负责人:ALEXEI A GROM
-
依托单位:
Pathobiology of the Monomyelocytoid Cell Gene Expression Signature in SystemicJIA
-
批准号:8727968
-
项目类别:
-
资助金额:$23.32万
-
财政年份:2003
-
负责人:ALEXEI A GROM
-
依托单位:
Pathobiology of the Monomyelocytoid Cell Gene Expression Signature in SystemicJIA
-
批准号:8380036
-
项目类别:
-
资助金额:$17.79万
-
财政年份:2003
-
负责人:ALEXEI A GROM
-
依托单位:
Pathobiology of the Monomyelocytoid Cell Gene Expression Signature in SystemicJIA
-
批准号:8232610
-
项目类别:
-
资助金额:$14.27万
-
财政年份:2003
-
负责人:ALEXEI A GROM
-
依托单位:
Pathogenic Mechanisms of the Vasculopathy of JDM
-
批准号:6734047
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2003
-
负责人:ALEXEI A GROM
-
依托单位:
Macrophage Activation Syndrome Biomarkers in Systemic Juvenile Idiopathic Art
-
批准号:8121401
-
项目类别:
-
资助金额:$17.73万
-
财政年份:--
-
负责人:ALEXEI A GROM
-
依托单位:
Macrophage Activation Syndrome Biomarkers in Systemic Juvenile Idiopathic Art
-
批准号:8314084
-
项目类别:
-
资助金额:$24.67万
-
财政年份:--
-
负责人:ALEXEI A GROM
-
依托单位:
海外基金